241 related articles for article (PubMed ID: 2428529)
1. The role of myelin lipids in experimental allergic encephalomyelitis. III. Transfer of suppression from guinea pigs recovering from EAE, induced by myelin basic protein--galactocerebroside complexes.
Hosein ZZ; Gilbert JJ; Strejan GH
Cell Immunol; 1986 Apr; 99(1):265-78. PubMed ID: 2428529
[TBL] [Abstract][Full Text] [Related]
2. The role of myelin lipids in experimental allergic encephalomyelitis. Part 2. Influence on disease production by encephalitogenic doses of myelin basic protein.
Hosein ZZ; Gilbert JJ; Strejan GH
J Neuroimmunol; 1986 Jan; 10(3):219-33. PubMed ID: 2416773
[TBL] [Abstract][Full Text] [Related]
3. Serum lipids and demyelination in experimental allergic encephalomyelitis induced by the increased encephalitogenicity of myelin basic protein given with galactocerebrospide.
Krzalić LJ; Nedeljković DR; Cvetković DH; Skender MK
J Neuroimmunol; 1989 May; 22(3):193-9. PubMed ID: 2467917
[TBL] [Abstract][Full Text] [Related]
4. Antigen-driven bystander suppression after oral administration of antigens.
Miller A; Lider O; Weiner HL
J Exp Med; 1991 Oct; 174(4):791-8. PubMed ID: 1717632
[TBL] [Abstract][Full Text] [Related]
5. Treatment of spinal cord-induced experimental allergic encephalomyelitis in the Lewis rat with liposomes presenting central nervous system antigens.
Stein CS; St Louis J; Gilbert JJ; Strejan GH
J Neuroimmunol; 1990 Jul; 28(2):119-30. PubMed ID: 1694533
[TBL] [Abstract][Full Text] [Related]
6. The role of myelin lipids in experimental allergic encephalomyelitis. Part 1. Influence on disease production by non-encephalitogenic doses of myelin basic protein.
Hosein ZZ; Gilbert JJ; Strejan GH
J Neuroimmunol; 1984 Dec; 7(2-3):163-78. PubMed ID: 6210304
[TBL] [Abstract][Full Text] [Related]
7. Suppression of experimental allergic encephalomyelitis in Lewis rats treated with myelin basic protein-liposome complexes: clinical, histopathological, and cell-mediated immunity correlates.
Strejan GH; Percy DH; St Louis J
Cell Immunol; 1984 Mar; 84(1):171-84. PubMed ID: 6199120
[TBL] [Abstract][Full Text] [Related]
8. Adoptive transfer of experimental allergic encephalomyelitis: recipient response to myelin basic protein-reactive lymphocytes.
Bouwer HG; Hinrichs DJ
J Neuroimmunol; 1994 Oct; 54(1-2):87-98. PubMed ID: 7523447
[TBL] [Abstract][Full Text] [Related]
9. Suppression of acute and chronic experimental allergic encephalomyelitis in Strain 13 guinea pigs. A clinical and pathological study.
Raine CS; Snyder DH; Stone SH; Bornstein MB
J Neurol Sci; 1977 Apr; 31(3):355-67. PubMed ID: 845617
[TBL] [Abstract][Full Text] [Related]
10. Suppression of experimental allergic encephalomyelitis by MBP-coupled lymphoid cells and by MBP-liposomes: a comparison.
Strejan GH; St Louis J
Cell Immunol; 1990 May; 127(2):284-98. PubMed ID: 1691689
[TBL] [Abstract][Full Text] [Related]
11. Suppression of acute experimental allergic encephalomyelitis in guinea pigs by prior transfer of suboptimal numbers of EAE-effector cells: induction of chronic EAE in whole tissue-sensitized guinea pigs.
Driscoll BF; Kies MW; Alvord EC
J Immunol; 1982 Feb; 128(2):635-8. PubMed ID: 6172501
[TBL] [Abstract][Full Text] [Related]
12. Induction of experimental autoimmune encephalomyelitis in guinea pigs using myelin basic protein and myelin glycolipids.
Kusunoki S; Yu RK; Kim JH
J Neuroimmunol; 1988 Jul; 18(4):303-14. PubMed ID: 2454944
[TBL] [Abstract][Full Text] [Related]
13. Experimental autoimmune encephalomyelitis. Augmentation of demyelination by different myelin lipids.
Moore GR; Traugott U; Farooq M; Norton WT; Raine CS
Lab Invest; 1984 Oct; 51(4):416-24. PubMed ID: 6207382
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.
Liu JQ; Bai XF; Shi FD; Xiao BG; Li HL; Levi M; Mustafa M; Wahren B; Link H
Int Immunol; 1998 Aug; 10(8):1139-48. PubMed ID: 9723700
[TBL] [Abstract][Full Text] [Related]
15. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. V. Hierarchy of suppression by myelin basic protein from different species.
Miller A; Lider O; al-Sabbagh A; Weiner HL
J Neuroimmunol; 1992 Aug; 39(3):243-50. PubMed ID: 1379607
[TBL] [Abstract][Full Text] [Related]
16. Suppression of experimental allergic encephalomyelitis in guinea/pigs by liposome-associated human myelin basic protein.
Strejan GH; Percy DH; St Louis J; Surlan D; Paty DW
J Immunol; 1981 Nov; 127(5):2064-9. PubMed ID: 6170686
[TBL] [Abstract][Full Text] [Related]
17. T-cell vaccination prevents EAE effector cell development but does not inhibit priming of MBP responsive cells.
Bouwer HG; Hinrichs DJ
J Neurosci Res; 1996 Aug; 45(4):455-62. PubMed ID: 8872906
[TBL] [Abstract][Full Text] [Related]
18. Successful immunization against experimental allergic encephalomyelitis with myelin basic protein-sensitized allogeneic lymphocytes.
Hashim GA
Neurochem Res; 1981 Jun; 6(6):699-718. PubMed ID: 6168929
[TBL] [Abstract][Full Text] [Related]
19. Effect of timing of intravenous administration of myelin basic protein on the induction of tolerance in experimental allergic encephalomyelitis.
Hilliard B; Ventura ES; Rostami A
Mult Scler; 1999 Feb; 5(1):2-9. PubMed ID: 10096096
[TBL] [Abstract][Full Text] [Related]
20. Effect of treatment with glutaraldehyde-fixed myelin basic protein-liposomes on active induction and passive transfer of experimental allergic encephalomyelitis in Lewis rats.
Strejan GH; Gilbert JJ; St Louis J
Cell Immunol; 1988 Oct; 116(1):250-6. PubMed ID: 2458844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
